About Cogentix Medical
Cogentix Medical is a company based in Orangeburg (United States) founded in 1987 was acquired by Laborie Medical in February 2018. Cogentix Medical has raised $25 million across 1 funding round from investors including Laborie Medical and Accelmed. The company has 141 employees as of December 31, 2018. Cogentix Medical operates in a competitive market with competitors including Amphora Medical, EMKinetics, EBT Medical, Valencia Technologies and BlueWind Medical, among others.
- Headquarter Orangeburg, United States
- Employees 141 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cogentix Medical Inc /De/
-
Annual Revenue
$56.32 M (USD)9as on Dec 31, 2017
-
Net Profit
-$882.75 K (USD)96as on Dec 31, 2017
-
EBITDA
-$889.47 K (USD)51as on Dec 31, 2017
-
Total Equity Funding
$25 M (USD)
in 1 rounds
-
Latest Funding Round
$25 M (USD), Private Equity Round
Sep 07, 2016
-
Investors
Laborie Medical
& 1 more
-
Employee Count
141
as on Dec 31, 2018
-
Acquired by
Laborie Medical
(Feb 12, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cogentix Medical
Cogentix Medical has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $25 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cogentix Medical
Cogentix Medical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Laborie Medical and Accelmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Medical products for female lower urinary tract dysfunctions are provided.
|
Locked | Locked | Locked |
Investor details for Cogentix Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cogentix Medical
Investment portfolio details for Cogentix Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cogentix Medical
Detailed financials for Cogentix Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cogentix Medical Comparisons
Peer comparison for Cogentix Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cogentix Medical
Cogentix Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amphora Medical, EMKinetics, EBT Medical, Valencia Technologies and BlueWind Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radiofrequency ablation device for overactive bladder treatment
|
|
| Locked | Locked | Locked |
Transdermal stimulation therapy is provided for urinary incontinence treatment.
|
|
| Locked | Locked | Locked |
Non-invasive neurostimulation devices for overactive bladder are developed.
|
|
| Locked | Locked | Locked |
A coin-sized neuromodulation device for hypertension treatment is developed.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for overactive bladder treatment are developed.
|
Detailed competitors of Cogentix Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cogentix Medical
Complete news archive for Cogentix Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cogentix Medical
Cogentix Medical was founded in 1987 and raised its 1st funding round 29 years after it was founded.
Cogentix Medical is headquartered in Orangeburg, United States. It is registered at Orangeburg, South Carolina, United States.
Cogentix Medical is a funded company, having raised a total of $25M across 1 funding round to date.
As of Dec 31, 2018, the latest employee count at Cogentix Medical is 141.
Annual revenue of Cogentix Medical is $56.32M as on Dec 31, 2017.
Cogentix Medical develops prescription-only (Rx) mininally invasive products used in the treatment of voiding dysfunctions and endoscopy solutions. The products include the Urgent PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and Urinal Incontinence (an FDA-cleared system that is also indicated for the treatment of fecal incontinence outside the US market); Macroplastique - for Stress Urinary Incontinence (SUI);and EndoSheath Endoscopy- an FDA-cleared, sterile, single-use product.
Cogentix Medical's top competitors include Valencia Technologies, Amphora Medical and EMKinetics.
Cogentix Medical has 2 investors. Key investors include Laborie Medical, and Accelmed.